Mainstay Capital Management LLC Astrazeneca PLC Transaction History

Mainstay Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Mar 04, 2021	SELL	$48.52 - $58.02 $354,390 - $423,778	-7,304 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $6,368 - $7,332	-120 Reduced 1.62%	7,304 $400,000
Q2 2020 Jul 23, 2020	BUY	$43.1 - $55.31 $24,567 - $31,526	570 Added 8.32%	7,424 $392,000
Q1 2020 Apr 23, 2020	BUY	$37.79 - $51.33 $38,734 - $52,613	1,025 Added 17.58%	6,854 $305,000
Q4 2019 Jan 21, 2020	SELL	$42.46 - $50.46 $77,701 - $92,341	-1,830 Reduced 23.89%	5,829 $291,000
Q2 2019 Aug 07, 2019	BUY	$37.28 - $41.68 $285,527 - $319,227	7,659 New	7,659 $316,000
Q4 2018 Feb 08, 2019	SELL	$36.86 - $41.49 $8,072 - $9,086	-219 Closed	0 $0
Q2 2018 Aug 23, 2018	BUY	$34.55 - $37.05 $34 - $37	1 Added 0.46%	219 $8,000
Q1 2018 May 10, 2018	SELL	$32.97 - $36.63 $32 - $36	-1 Reduced 0.46%	218 $7,000
Q4 2017 Mar 28, 2018	BUY	$32.09 - $34.78 $7,027 - $7,616	219	219 $8,000

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Mainstay Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mainstay Capital Management LLC with notifications on news.